Lenvatinib, CAS [[417716-92-8]]
Artikelnummer:
MCE-HY-10981
| Artikelname: |
Lenvatinib, CAS [[417716-92-8]] |
| Artikelnummer: |
MCE-HY-10981 |
| Hersteller Artikelnummer: |
HY-10981 |
| Alternativnummer: |
MCE-HY-10981-50MG,MCE-HY-10981-10MG,MCE-HY-10981-200MG,MCE-HY-10981-100MG,MCE-HY-10981-5MG,MCE-HY-10981-10MMX1ML,MCE-HY-10981-500MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
E7080 |
| Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities[1][2]. |
| Molekulargewicht: |
426.85 |
| Reinheit: |
99.75 |
| CAS Nummer: |
[417716-92-8] |
| Formel: |
C21H19ClN4O4 |
| Target-Kategorie: |
c-Kit,FGFR,PDGFR,RET,VEGFR |
| Anwendungsbeschreibung: |
MCE Product type: Reference compound1 |
